Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

Xtant Medical Holdings, Inc.

XTNT · NYSE · CIK 0001453593 · Healthcare · Medical Devices

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

11 Form 4 transaction lines observed in the same window
0 sales · 11 option, withholding, award, gift or other lines

Last qualifying purchase2023-11-17 · Brandt Kevin D · $50.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Schallenberger Mark A.Chief Operating Officer
○○
Neils Scott CCFO and Assistant Secretary
○○
Browne Sean EPresident and CEO
○○
Lipschultz TylerDirector
○
BAKEWELL JOHN KDirector
○
Beeson Jonn R.Director
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-11-17 · Brandt Kevin D.

Recent Form 4 activity

0Purchases
0Sales
22Other Form 4 lines
19SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER11 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
143,564
Previous report
268,742
Avg daily volume
239,833
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2023-11-17Brandt Kevin DPurchase (P)Common Stock41,670USD 1.20USD 50,004SEC filing ↗
2022-10-07Vizirgianakis Stavros G.Purchase (P)Common Stock, $0.000001 par value2,264,861USD 0.48USD 1,087,133SEC filing ↗

Form 4 evidence

22 transaction lines in the latest 365-day window; 117 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-15Vizirgianakis Stavros G.Award / grant (A)Common Stock323,275USD 0.00USD 0SEC filing ↗
2026-08-15Schallenberger Mark A.Tax withholding (F)Common Stock7,070USD 0.31USD 2,192SEC filing ↗
2026-08-15Schallenberger Mark A.Award / grant (A)Common Stock450,000USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (22 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-15Vizirgianakis Stavros G.Award / grant (A)Common Stock323,275USD 0.00USD 0SEC filing ↗
2026-08-15Schallenberger Mark A.Tax withholding (F)Common Stock7,070USD 0.31USD 2,192SEC filing ↗
2026-08-15Schallenberger Mark A.Award / grant (A)Common Stock450,000USD 0.00USD 0SEC filing ↗
2026-08-15Neils Scott CTax withholding (F)Common Stock28,155USD 0.31USD 8,728SEC filing ↗
2026-08-15Neils Scott CAward / grant (A)Common Stock400,000USD 0.00USD 0SEC filing ↗
2026-08-15Lipschultz TylerAward / grant (A)Common Stock215,517USD 0.00USD 0SEC filing ↗
2026-08-15JAIN ABHINAVAward / grant (A)Common Stock215,517USD 0.00USD 0SEC filing ↗
2026-08-15Browne Sean ETax withholding (F)Common Stock10,605USD 0.31USD 3,288SEC filing ↗
2026-08-15Browne Sean EAward / grant (A)Common Stock550,000USD 0.00USD 0SEC filing ↗
2026-08-15Beeson Jonn R.Award / grant (A)Common Stock215,517USD 0.00USD 0SEC filing ↗
2026-08-15BAKEWELL JOHN KAward / grant (A)Common Stock215,517USD 0.00USD 0SEC filing ↗
2026-02-15Schallenberger Mark A.Tax withholding (F)Common Stock7,709USD 0.58USD 4,471SEC filing ↗
2026-01-15Neils Scott CTax withholding (F)Common Stock8,084USD 0.65USD 5,255SEC filing ↗
2025-11-15Vizirgianakis Stavros G.Award / grant (A)Common Stock553,797USD 0.00USD 0SEC filing ↗
2025-11-15Schallenberger Mark A.Award / grant (A)Common Stock292,253USD 0.00USD 0SEC filing ↗
2025-11-15Neils Scott CAward / grant (A)Common Stock263,291USD 0.00USD 0SEC filing ↗
2025-11-15Lipschultz TylerAward / grant (A)Common Stock158,228USD 0.00USD 0SEC filing ↗
2025-11-15JAIN ABHINAVAward / grant (A)Common Stock158,228USD 0.00USD 0SEC filing ↗
2025-11-15Browne Sean EAward / grant (A)Common Stock394,937USD 0.00USD 0SEC filing ↗
2025-11-15Beeson Jonn R.Award / grant (A)Common Stock158,228USD 0.00USD 0SEC filing ↗
2025-11-15BAKEWELL JOHN KAward / grant (A)Common Stock158,228USD 0.00USD 0SEC filing ↗
2025-11-15BAKEWELL JOHN KAward / grant (A)Common Stock158,228USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerXTNT
CIK0001453593
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeNYSE

Data coverage

Local Form 4 history117 transaction lines from 2020-02-05 to 2026-08-15
2 P purchase lines · 9 S sale lines · 106 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.